Aubagio ‘slows brain atrophy in RRMS patients’
Aubagio ‘slows brain atrophy in RRMS patients’
Genzyme has announced results from magnetic resonance imaging (MRI) analysis of participants in the Phase III TEMSO clinical trial showing Aubagio was able to slow the loss of brain volume (or atrophy) versus a placebo over two years in patients with relapsing-remitting multiple sclerosis (RRMS)... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 11924 Views
-
Last post by accordingnature495
-
- 0 Replies
- 1889 Views
-
Last post by NHE
-
- 0 Replies
- 1589 Views
-
Last post by NHE
-
- 4 Replies
- 1562 Views
-
Last post by NHE
-
- 0 Replies
- 1259 Views
-
Last post by NHE
-
- 0 Replies
- 1598 Views
-
Last post by NHE
-
- 0 Replies
- 2061 Views
-
Last post by frodo
-
- 0 Replies
- 2154 Views
-
Last post by NHE
-
- 0 Replies
- 1702 Views
-
Last post by NHE